GLP-1 agonists -- which include blockbusters such as semaglutide (Rybelsus, Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) -- were initially approved for type 2 diabetes before gaining ...

Share on Twitter Print Share by Email Share Back to top In spring 2025, the Food and Drug Administration (FDA) resolved and ended the ...

Novo Nordisk A/S NVO reported second-quarter 2025 earnings of 97 cents per American Depositary Receipt (ADR), which beat the Zacks Consensus Estimate of 93 cents. The company had reported earnings of ...

As of 2024, Medicare Part D covers Ozempic, Mounjaro, Rybelsus (semaglutide), and Wegovy for FDA-approved conditions. But they are not covered for weight loss.

Semaglutide is the active ingredient in the weight loss medication Wegovy and the diabetes drugs Ozempic and Rybelsus, which ...

Weight loss medications like Wegovy can be life-changing for people living with obesity or excess weight with related health ...

DehydraTECH-semaglutide reduces overall side effects by 36.5% as compared to Rybelsus® DehydraTECH-semaglutide reduces gastrointestinal side effects by 43.5% as compared to Rybelsus® DehydraTECH-GLP-1 ...

Ozempic may be more expensive and harder to find now that compounded semaglutide isn’t available. Here are seven reputable places to get a prescription online.

Windsor EV, the popular electric vehicle from MG, is the brand''''s best-selling model in India. Tap for more information.

MG has clearly been eyeing the Tesla Model 3 as in many ways the IM5 matches – and sometimes beats – Tesla’s big-selling saloon. It’s close on price, tech, range and performance, but with ...